Q BioMed Inc (QBIO)
0.0005
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Q BioMed Cash from Operations (TTM): 2.180M for Feb. 28, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| February 28, 2023 | 2.180M |
| November 30, 2022 | 1.941M |
| August 31, 2022 | -2.286M |
| May 31, 2022 | -2.887M |
| February 28, 2022 | -3.862M |
| November 30, 2021 | -4.302M |
| August 31, 2021 | -4.214M |
| May 31, 2021 | -5.067M |
| February 28, 2021 | -5.654M |
| November 30, 2020 | -6.233M |
| August 31, 2020 | -5.790M |
| May 31, 2020 | -4.586M |
| February 29, 2020 | -4.131M |
| November 30, 2019 | -4.105M |
| August 31, 2019 | -4.543M |
| May 31, 2019 | -5.591M |
| February 28, 2019 | -6.238M |
| Date | Value |
|---|---|
| November 30, 2018 | -6.451M |
| August 31, 2018 | -6.644M |
| May 31, 2018 | -6.399M |
| February 28, 2018 | -5.942M |
| November 30, 2017 | -5.584M |
| August 31, 2017 | -4.600M |
| May 31, 2017 | -3.588M |
| February 28, 2017 | -2.425M |
| November 30, 2016 | -1.545M |
| August 31, 2016 | -0.9472M |
| May 31, 2016 | -0.6679M |
| February 29, 2016 | -0.4276M |
| November 30, 2015 | -0.0914M |
| August 31, 2015 | -0.0315M |
| May 31, 2015 | -0.0368M |
| February 28, 2015 | -0.0389M |
| November 30, 2014 | -0.0374M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-6.233M
Minimum
Nov 2020
2.180M
Maximum
Feb 2023
-3.696M
Average
-4.258M
Median
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |